Morgan Stanley analysts have estimated that Lilly’s GLP-1 pill could bring in as much as $40 billion in annual sales by 2033.

Second Nature will maintain existing September prices across all doses of Mounjaro for its members, absorbing the cost ...

A DAILY weight loss pill, tipped to be cheaper than popular jabs, has helped patients shed nearly two stone in trials. People ...

Now, one Wegovy user who's been on the medication for only a week has shared an unexpected side effect of the drug - but they ...

A competitor reported a successful late-stage clinical trial of a drug that could be very competitive with Wegovy.

GLP-1 drugs may lower the risk of some obesity-related cancers, according to an observational study of people who were ...

Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory ...

GLP-1 medications have been known to come with a raft of side effects, including weight loss and drastic changes to users' ...

In a study of more than 1,600 adults with type 2 diabetes, those who received the highest dose of orforglipron on average shed 10.5% of their weight.

With around 73 percent of Americans enjoying their daily coffee fix, it’s natural to wonder how your morning cup might ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

A growing number of patients claim popular weight loss and diabetes drugs like Ozempic can cause a rare but very serious side ...